These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1166 related articles for article (PubMed ID: 9044744)

  • 1. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
    Szala S; Missol E; Sochanik A; Strozyk M
    Gene Ther; 1996 Nov; 3(11):1026-31. PubMed ID: 9044744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency.
    Esposito C; Generosi J; Mossa G; Masotti A; Castellano AC
    Colloids Surf B Biointerfaces; 2006 Dec; 53(2):187-92. PubMed ID: 17049213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene.
    Missol-Kolka E; Sochanik A; Szala S
    Neoplasma; 1998; 45(5):305-11. PubMed ID: 9921920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
    Maitani Y; Igarashi S; Sato M; Hattori Y
    Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
    Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
    Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between structure and transfection efficiency: a study of DC-Chol--DOPE/DNA complexes.
    Congiu A; Pozzi D; Esposito C; Castellano C; Mossa G
    Colloids Surf B Biointerfaces; 2004 Jul; 36(1):43-8. PubMed ID: 15261022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes.
    Keller M; Jorgensen MR; Perouzel E; Miller AD
    Biochemistry; 2003 May; 42(20):6067-77. PubMed ID: 12755608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
    Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
    Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoplex formation using liposomes prepared by ethanol injection.
    Maitani Y
    Methods Mol Biol; 2010; 605():393-403. PubMed ID: 20072896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
    Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes.
    Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E
    Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy.
    Kanyama H; Tomita N; Yamano T; Aihara T; Miyoshi Y; Ohue M; Sekimoto M; Sakita I; Tamaki Y; Kaneda Y; Senter PD; Monden M
    Cancer Res; 2001 Jan; 61(1):14-8. PubMed ID: 11196152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.
    Murray KD; Etheridge CJ; Shah SI; Matthews DA; Russell W; Gurling HM; Miller AD
    Gene Ther; 2001 Mar; 8(6):453-60. PubMed ID: 11313824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.
    Zhao DD; Watarai S; Lee JT; Kouchi S; Ohmori H; Yasuda T
    Acta Med Okayama; 1997 Jun; 51(3):149-54. PubMed ID: 9227794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes.
    Hwang SH; Hayashi K; Takayama K; Maitani Y
    Gene Ther; 2001 Aug; 8(16):1276-80. PubMed ID: 11509962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physicochemical characterization of the interaction between DC-Chol/DOPE cationic liposomes and DNA.
    Rodríguez-Pulido A; Ortega F; Llorca O; Aicart E; Junquera E
    J Phys Chem B; 2008 Oct; 112(39):12555-65. PubMed ID: 18729499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase gene.
    Szary J; Missol E; Tarnawski R; Szala S
    Cancer Gene Ther; 1997; 4(4):269-72. PubMed ID: 9253513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.